Retrospective Cohort Study
Copyright ©The Author(s) 2022.
World J Gastrointest Endosc. Nov 16, 2022; 14(11): 672-683
Published online Nov 16, 2022. doi: 10.4253/wjge.v14.i11.672
Table 5 Multivariate regression analysis for detection rates of cancer, adenomas, and serrated lesions amongst eligible procedures

Coefficient
OR (95%CI)
P value
Cancer
Site0.111.11 (0.87-1.43)0.40
Patient age0.041.04 (1.02-1.07)< 0.001
Patient gender (male)-0.450.64 (0.36-1.14)0.13
Trainee (present)-0.120.89 (0.46-1.73)0.73
Proceduralist (medical)1-0.610.54 (0.30-0.97)0.04
Adenomas
Site-0.010.99 (0.90-1.09)0.84
Patient age0.041.04 (1.03-1.05)< 0.001
Patient gender (male)-0.650.53 (0.42-0.65)< 0.001
Trainee (present)0.221.24 (0.96-1.61)0.10
Proceduralist (medical)10.341.41 (1.13-1.76)0.002
Serrated lesions
Site0.081.08 (0.90-1.3)0.42
Patient age0.001.00 (0.99-1.02)0.57
Patient gender (male)0.411.51 (0.99-2.29)0.05
Trainee (present)0.261.29 (0.78-2.14)0.33
Proceduralist (medical)10.281.32 (0.87-2.02)0.19